SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 20, 2002
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware 1-12091 22-3436215
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation or organization) Identification Number)
230 Half Mile Road
Red Bank, New Jersey 07701
(Address of principal executive offices)
Registrant's telephone number, including area code: (732) 933-5000
Item 9. Regulation FD Disclosure.
------------------------
On March 20, 2002, the registrant made the investor presentation filed
as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
---------------------------------
Exhibit Description
------- -----------
99.1 Investor Presentation by William M.
Landuyt, Chief Executive Officer, at
Merrill Lynch Chemical Conference held on
March 20, 2002
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on behalf of the
undersigned hereunto duly authorized.
Dated: March 20, 2002
MILLENNIUM CHEMICALS INC.
By:/s/ C. William Carmean
----------------------
C. William Carmean
Vice President
3
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Investor Presentation by William M.
Landuyt, Chief Executive Officer, at
Merrill Lynch Chemical Conference held on
March 20, 2002
4